Introduction
In order to meet the goals set at the Lisbon Summit, March 2000, to prepare Europe ’s transition to becoming the most competitive, dynamic, knowledge-based economy in the world, significant emphasis must be placed on scientific research and technology development. This was further emphasized at the Barcelona European Council in 2002, which determined an effort was needed to accelerate Europe ’s investment in research to a level of 3 percent of GDP by 2010. To accomplish this level of investment in research, there must be consistent growth through leveraging opportunities.
SYNBIOLOGY is an ambitious NEST project d esigned to identify key attributes of synthetic biology research in Europe and North America (USA and Canada), and determine potential differences in research environments (including funding arrangements) across European countries, USA and Canada that impact the level and nature of synthetic biology research and the short and long–run commercial possibilities.
This will be accomplished through a comprehensive study that includes a review of relevant studies, and identification and survey of Key Stakeholders representing research, industry and government. The results will be used as a basis on which the EC can provide policy and funding options to maximize the effectiveness of its support to synthetic biology. The results of the project will be disseminated widely to policy makers and synthetic biology sector participants via a seminar, an interactive website and other dissemination activities.
LEGAL NOTICE:
Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of the following information.
The views expressed in this website are the sole responsibility of the consortium and do not necessarily reflect the views of the European Commission.